Arrowstreet Capital’s ATRenew RERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.4M Sell
2,861,027
-39,320
-1% -$222K 0.01% 858
2025
Q4
$15.4M Sell
2,900,347
-49,805
-2% -$223K 0.01% 811
2025
Q3
$13.6M Buy
2,950,152
+1,466,383
+99% +$5.9M 0.01% 860
2025
Q2
$4.91M Sell
1,483,769
-101,171
-6% -$263K ﹤0.01% 1173
2025
Q1
$4.66M Sell
1,584,940
-51,533
-3% -$151K ﹤0.01% 1046
2024
Q4
$4.71M Buy
1,636,473
+822,998
+101% +$2.29M ﹤0.01% 1027
2024
Q3
$322K Buy
813,475
+354,174
+77% +$862K ﹤0.01% 1584
2024
Q2
$1.09M Buy
459,301
+259,566
+130% +$569K ﹤0.01% 1201
2024
Q1
$352K Buy
+199,735
New +$266K ﹤0.01% 1510

Other funds holding RERE

Arrowstreet Capital's RERE Position: Q1 2026 in Review

Arrowstreet Capital reduced its ATRenew (RERE) stake by 1.4% in Q1 2026, selling an estimated $222K and leaving 2,861,027 shares worth $13.4M. The position accounts for 0.01% of the portfolio, ranked #858.

Arrowstreet Capital first reported a position in RERE in Q1 2024 and has held it in 9 quarters since. The position peaked at $15.4M in Q4 2025. 81 funds tracked by Wall St. Rank hold RERE as of Q1 2026.

  • Arrowstreet Capital held 2,861,027 shares of ATRenew worth $13.4M as of Q1 2026.
  • Arrowstreet Capital sold 39,320 ATRenew shares in Q1 2026, an estimated $222K.
  • ATRenew made up 0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #858 holding.
  • Arrowstreet Capital first reported a position in ATRenew in Q1 2024 and has held it in 9 quarters since.
  • Arrowstreet Capital's ATRenew position peaked at $15.4M in Q4 2025.
  • 81 funds tracked by Wall St. Rank held ATRenew as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.